High Fibrosis-4 is Associated With Increased Risk of Cirrhosis Decompensation and Liver-Related Mortality in at-Risk Patients With Metabolic Dysfunction–Associated Steatotic Liver... by Elizabeth E. Powell, Gunter Hartel, Katharine M. Irvine, James O’Beirne, Vikas Bhasker, Patricia C. Valery

Get full text

Depressive symptoms in non-alcoholic fatty liver disease are identified by perturbed lipid and lipoprotein metabolism. by Daniel E Radford-Smith, Preya J Patel, Katharine M Irvine, Anthony Russell, Dan Siskind, Daniel C Anthony, Elizabeth E Powell, Fay Probert

Get full text

Implementation of a nurse-delivered, community-based liver screening and assessment program for people with metabolic dysfunction-associated steatotic liver disease (LOCATE-NAFLD t... by Michelle J. Allen, Ruth Tulleners, David Brain, James O’Beirne, Elizabeth E. Powell, Adrian Barnett, Patricia C. Valery, Sanjeewa Kularatna, Ingrid J. Hickman

Get full text

ICD-10-AM codes for cirrhosis and related complications: key performance considerations for population and healthcare studies by Kelly L Hayward, Amy L Johnson, Benjamin J Mckillen, Vikas Bansal, Leigh U Horsfall, Gunter Hartel, Chris Moser, Elizabeth E Powell, Patricia C Valery

Get full text

Alcohol Consumption in Diabetic Patients with Nonalcoholic Fatty Liver Disease by Preya J. Patel, David Smith, Jason P. Connor, Leigh U. Horsfall, Kelly L. Hayward, Fabrina Hossain, Suzanne Williams, Tracey Johnson, Katherine A. Stuart, Nigel N. Brown, Nivene Saad, Andrew D. Clouston, Katharine M. Irvine, Anthony W. Russell, Patricia C. Valery, Elizabeth E. Powell

Get full text